Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 2 of the 13 calendar months from Oct 2025 to Oct 2026: Nov 2025 and Dec 2025.
- Largest single sale: $14.2M (32,234 shares) of Vertex Pharmaceuticals on Nov 14, 2025. Filing
- Last sale before this period: Aug 30, 2024.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Odyssey Therapeutics, Inc. (ODTX) | Director | May 7, 2026 | May 11, 2026 |
| Vertex Pharmaceuticals (VRTX) | Executive Chairman, Director | Jul 7, 2009 | Feb 26, 2026 |
| Quest Diagnostics (DGX) | Former Director | Dec 3, 2014 | May 30, 2018 |
| Abbott Laboratories (ABT) | Former President and COO, Director | Feb 18, 2004 | Mar 28, 2006 |
Also a director at
Vertex Pharmaceuticals (VRTX), Quest Diagnostics (DGX) (no filing in the last 18 months), Abbott Laboratories (ABT) (no filing in the last 18 months)
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- May 11, 2026, Odyssey Therapeutics, Inc.: 28,698 shares converted; 2,963 shares vested or acquired by exercising options; 17 shares withheld by the company for taxes (some held indirectly). 1 filing: 1
- May 8, 2026, Odyssey Therapeutics, Inc.: bought 5,000 shares for $100K. 1 filing: 1
- Feb 24, 2026, Vertex Pharmaceuticals: 3,547 shares withheld by the company for taxes. 1 filing: 1
- Feb 18, 2026, Vertex Pharmaceuticals: 2,964 shares withheld by the company for taxes. 1 filing: 1
- Feb 17, 2026, Vertex Pharmaceuticals: 8,269 shares granted. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.